WorldUpstart Announces Companies Selected for the Winter 2025 U.S. Market Gateway Accelerator
Stephanie Vogel Stephanie Vogel

WorldUpstart Announces Companies Selected for the Winter 2025 U.S. Market Gateway Accelerator

WorldUpstart proudly announces the launch of its Winter 2025 U.S. Market Gateway Accelerator, featuring ten innovative Life Science and MedTech companies poised for significant growth. This 8-week hybrid program, commencing online on February 10, 2025, culminates in a high-impact visit to Philadelphia from May 5-6, 2025.

This year's participants were selected from a competitive pool of over 100 applicants, including startups and established companies specializing in Drug Development, Medical Devices, and Digital Health from around the globe. The chosen companies, representing Canada, France, India, Israel, Italy, Norway, Poland, Sweden, Switzerland, and the United Kingdom, are set to embark on a journey to expand into the dynamic U.S. market. Through WorldUpstart's intensive accelerator program, these companies will gain valuable insights, mentorship, and access to strategic networks, providing them with the tools and support needed for a successful market entry.

Read More
Global Innovation Meets Local Ecosystem: PHL MedTech and Life Sciences Showcase
Stephanie Vogel Stephanie Vogel

Global Innovation Meets Local Ecosystem: PHL MedTech and Life Sciences Showcase

Philadelphia is emerging as a top destination for international startups entering the U.S. healthcare market, thanks to the success of WorldUpstart’s U.S. Market Gateway Accelerator. The program has supported 74 companies from 18 countries, connecting them with Philadelphia’s vibrant Life Sciences and MedTech ecosystem.

Read More
From Patents to Partnerships: Intellectual Property Tactics for MedTech and Life Sciences Growth in the U.S.
Stephanie Vogel Stephanie Vogel

From Patents to Partnerships: Intellectual Property Tactics for MedTech and Life Sciences Growth in the U.S.

For over three years, WorldUpstart has been at the forefront of assisting BioSciences and MedTech companies from around the globe in successfully entering the U.S. market. With our focused expertise and extensive network, we have helped numerous firms navigate the complexities of market entry, bringing the right tools and knowledge to ensure success. This blog post draws on the deep expertise of Christopher Halliday from DLA Piper, our leading expert in IP protection and strategy, to provide invaluable insights for companies looking to secure their intellectual property while expanding into the U.S. market.

Read More